DIAMOND: Effect of Type of Head Positioning on Retinal Displacement in Vitrectomy for Retinal Detachment

Sponsor
Unity Health Toronto (Other)
Overall Status
Recruiting
CT.gov ID
NCT04035343
Collaborator
(none)
324
1
2
61.2
5.3

Study Details

Study Description

Brief Summary

Patients may experience metamorphopsia, or image distortion, after having vitrectomy to repair their rhegmatogenous retinal detachments especially those with a detached macula. Retinal displacement, as measured on autofluorescence photography, likely contributes to this distortion. It is thought that the retina slips inferiorly due to the residual subretinal fluid shifting as the patient transitions from the supine position intraoperatively to the sitting up position in the immediate postoperative period. By having the patient immediate position facedown or according to the retinal break, the risk of slippage is theoretically decreased.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Face down positioning
  • Behavioral: Supine positioning
N/A

Detailed Description

Rhegmatogenous retinal detachments (RRD) are a sight-threatening condition with an incidence of approximately 10 per 100 000 people. RRDs can be broadly classified into those with the macula still attached, and those with the macula detached. Visual prognosis for RRDs with attached macula tend to be much better than those with detached macula. Pars plana vitrectomy (PPV) is one of the procedures used to treat RRD. PPV is carried out in the operating room under regional anesthestic, and often times sedation. The retina is reattached by either draining the subretinal fluid through a peripheral retinal break, by draining the subretinal fluid through a posterior retinotomy, or by using a heavier-than-water liquid such as perfluorocarbon to push out the subretinal fluid. At the end of the surgery, the vitreous cavity is filled with a substance that will tamponade the retina to the wall of the eye. Tamponade agents can be temporary, such as sulfur hexafluoride (SF6) and octafluoropropane (C3F8), or long term, such as silicone oil. After the surgery, patients are usually told to put their facedown allowing the tamponade agent to keep the macula attached while the remaining subretinal fluid is reabsorbed by the retinal pigment epithelium. Alternatively, some surgeons ask that their patients position according to the location of their retinal breaks with the aim for the buoyant gas bubble to cover the break or breaks. Patients may experience metamorphopsia, or image distortion, after having their RRD repaired especially those with a detached macula. Retinal displacement, as measured on autofluorescence photography, likely contributes to this distortion. Supine positioning in theory covers all break locations as usually breaks occur in the anterior part of the retina near the vitreous base. This position has the advantage of being more ergonomic than face down. Depending on the results, this study might provide evidence for the current standard of care, which is face down positioning for the first day after vitrectomy for retinal detachment. Or, if supine positioning demonstrates superiority in reducing the risk of retinal displacement, patients would be able to maintain a more comfortable position after surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
324 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Difference In Anatomic Integrity in Vitrectomy for Macula Off Rhegmatogenous RetiNal Detachments With Face Down Compared to Supine Positioning (the DIAMOND Study)
Actual Study Start Date :
Aug 26, 2019
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional face down positioning

Patients in third arm will be treated with the current standard of care, that is, they will be kept supine in the ophthalmic surgery chair after the completion of their surgery. They will then be taken to the recovery area where, once transferred to the care of the postoperative care unit staff, they will transition to face down positioning. They will maintain this positioning until their first day postoperative visit after which they will position according to the retinal breaks found during surgery.

Behavioral: Face down positioning
See description of the face down positioning group

Experimental: Supine positioning

Patients in the second arm will be kept supine after the completion of their surgery. They will then be taken to the recovery area where, once transferred to the care of the postoperative care unit staff, they will maintain supine positioning. They will maintain this positioning until their first day postoperative visit after which they will position according to the retinal breaks found during surgery.

Behavioral: Supine positioning
See description of the supine positioning group

Outcome Measures

Primary Outcome Measures

  1. Retinal displacement [3 months]

    The presence of retinal vessels printing on fundus autofluorescence imaging.

Secondary Outcome Measures

  1. Visual Distortion [3 months]

    measured with M chart.

  2. Aniseikonia [3 months]

    Measured with aniseikonia testing. The aniseikonia test measures the ratio of image size difference between the 2 eyes

  3. Optical coherence tomography (OCT) changes [3 months]

    Changes seen on OCT

  4. Optical coherence tomography angiography (OCTA) changes [3 months]

    Changes seen on OCTA

  5. Metamorphopsia [3 months]

    Metamorphopsia is the image distortion experienced by the patient. It will be recorded in a data collection sheet as "yes" or "no" according to the patient subjective complain on metamorphopsia.

  6. Best corrected Visual Acuity measured in "Early Treatment of Diabetic Retinopathy Study" letters [3 months]

    Best corrected Visual Acuity measured in "Early Treatment of Diabetic Retinopathy Study" letters

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18

  • Diagnosis of primary rhegmatogenous retinal detachment needing pars plana vitrectomy with the detachment involving at least one of the temporal vascular arcades, which would allow retinal displacement to be detected on fundus autofluorescence photography

Exclusion Criteria:
  • Rhegmatogenous retinal detachment with an attached macula

  • Proliferative retinopathy grade C or worst

  • Prior vitrectomy for retinal detachment. Patients having had pneumatic retinopexy that failed to completely reattach the retina and therefore now needing vitrectomy are allowed into the study

  • History of preoperative binocular diplopia

  • Tamponade with silicone oil instead of gas

  • Inability to maintain post operation head positioning

  • Mental incapacity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Ophthalmology, St. Michael's Hospital Toronto Ontario Canada M5C 2T2

Sponsors and Collaborators

  • Unity Health Toronto

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Unity Health Toronto
ClinicalTrials.gov Identifier:
NCT04035343
Other Study ID Numbers:
  • 18-374
First Posted:
Jul 29, 2019
Last Update Posted:
Apr 28, 2021
Last Verified:
Apr 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2021